Annual Current Assets
$27.71 M
+$7.16 M+34.83%
31 December 2023
Summary:
Galectin Therapeutics annual total current assets is currently $27.71 million, with the most recent change of +$7.16 million (+34.83%) on 31 December 2023. During the last 3 years, it has fallen by -$1.75 million (-5.96%). GALT annual current assets is now -42.52% below its all-time high of $48.21 million, reached on 31 December 2019.GALT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$28.67 M
+$1.38 M+5.05%
30 September 2024
Summary:
Galectin Therapeutics quarterly total current assets is currently $28.67 million, with the most recent change of +$1.38 million (+5.05%) on 30 September 2024. Over the past year, it has increased by +$7.05 million (+32.65%). GALT quarterly current assets is now -45.60% below its all-time high of $52.70 million, reached on 30 June 2019.GALT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.8% | +32.6% |
| 3 y3 years | -6.0% | -24.6% |
| 5 y5 years | +213.8% | -43.2% |
GALT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.7% | +34.8% | -31.4% | +67.4% |
| 5 y | 5 years | -42.5% | +213.8% | -43.2% | +67.4% |
| alltime | all time | -42.5% | +9015.1% | -45.6% | >+9999.0% |
Galectin Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.67 M(+5.1%) |
| June 2024 | - | $27.29 M(+7.2%) |
| Mar 2024 | - | $25.46 M(-8.1%) |
| Dec 2023 | $490.00 K(-33.2%) | $27.71 M(+28.2%) |
| Sept 2023 | - | $21.61 M(+11.0%) |
| June 2023 | - | $19.47 M(-0.4%) |
| Mar 2023 | - | $19.55 M(-4.9%) |
| Dec 2022 | $733.00 K(>+9900.0%) | $20.55 M(+20.0%) |
| Sept 2022 | - | $17.12 M(-33.6%) |
| June 2022 | - | $25.79 M(-23.0%) |
| Mar 2022 | - | $33.51 M(-19.9%) |
| Dec 2021 | $7000.00(-94.8%) | $41.82 M(+10.1%) |
| Sept 2021 | - | $38.00 M(+14.0%) |
| June 2021 | - | $33.33 M(+46.2%) |
| Mar 2021 | - | $22.79 M(-22.6%) |
| Dec 2020 | $135.00 K(-47.7%) | $29.46 M(-13.0%) |
| Sept 2020 | - | $33.88 M(-17.6%) |
| June 2020 | - | $41.12 M(-6.3%) |
| Mar 2020 | - | $43.88 M(-9.0%) |
| Dec 2019 | $258.00 K(+48.3%) | $48.21 M(-4.5%) |
| Sept 2019 | - | $50.47 M(-4.2%) |
| June 2019 | - | $52.70 M(+604.2%) |
| Mar 2019 | - | $7.48 M(-15.3%) |
| Dec 2018 | $174.00 K(-49.1%) | $8.83 M(-16.1%) |
| Sept 2018 | - | $10.53 M(-4.6%) |
| June 2018 | - | $11.04 M(+136.2%) |
| Mar 2018 | - | $4.67 M(+22.4%) |
| Dec 2017 | $342.00 K(>+9900.0%) | $3.82 M(-45.5%) |
| Sept 2017 | - | $7.01 M(-24.8%) |
| June 2017 | - | $9.33 M(-33.4%) |
| Mar 2017 | - | $14.00 M(-11.4%) |
| Dec 2016 | $1000.00(-87.5%) | $15.79 M(-2.0%) |
| Sept 2016 | - | $16.11 M(-11.7%) |
| June 2016 | - | $18.24 M(-19.9%) |
| Mar 2016 | - | $22.78 M(-13.7%) |
| Dec 2015 | $8000.00(-50.0%) | $26.40 M(+22.8%) |
| Sept 2015 | - | $21.50 M(-19.4%) |
| June 2015 | - | $26.67 M(-11.0%) |
| Mar 2015 | - | $29.96 M(+1.0%) |
| Dec 2014 | $16.00 K(-38.5%) | $29.66 M(-5.2%) |
| Sept 2014 | - | $31.29 M(-9.3%) |
| June 2014 | - | $34.51 M(-6.1%) |
| Mar 2014 | - | $36.74 M(+243.8%) |
| Dec 2013 | $26.00 K(-40.9%) | $10.69 M(+9.7%) |
| Sept 2013 | - | $9.74 M(+87.8%) |
| June 2013 | - | $5.19 M(-27.5%) |
| Mar 2013 | - | $7.16 M(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $44.00 K(-60.4%) | $9.52 M(-14.6%) |
| Sept 2012 | - | $11.15 M(-15.6%) |
| June 2012 | - | $13.21 M(-14.3%) |
| Mar 2012 | - | $15.43 M(+137.3%) |
| Dec 2011 | $111.00 K(+5.7%) | $6.50 M(-18.7%) |
| Sept 2011 | - | $8.00 M(-0.7%) |
| June 2011 | - | $8.05 M(+14.7%) |
| Mar 2011 | - | $7.02 M(+13.3%) |
| Dec 2010 | $105.00 K(-20.5%) | $6.20 M(+116.3%) |
| Sept 2010 | - | $2.86 M(-2.3%) |
| June 2010 | - | $2.93 M(+1555.4%) |
| Mar 2010 | - | $177.00 K(-41.8%) |
| Dec 2009 | $132.00 K(-59.3%) | $304.00 K(-41.7%) |
| Sept 2009 | - | $521.00 K(-50.9%) |
| June 2009 | - | $1.06 M(+14.6%) |
| Mar 2009 | - | $926.00 K(+143.7%) |
| Dec 2008 | $324.00 K(-17.6%) | $380.00 K(-57.5%) |
| Sept 2008 | - | $895.00 K(-45.8%) |
| June 2008 | - | $1.65 M(-52.3%) |
| Mar 2008 | - | $3.46 M(+149.1%) |
| Dec 2007 | $393.00 K(-8.0%) | $1.39 M(+14.0%) |
| Sept 2007 | - | $1.22 M(-51.3%) |
| June 2007 | - | $2.50 M(-44.1%) |
| Mar 2007 | - | $4.47 M(-24.6%) |
| Dec 2006 | $427.00 K(+58.7%) | $5.94 M(-28.3%) |
| Sept 2006 | - | $8.28 M(-17.0%) |
| June 2006 | - | $9.97 M(-17.7%) |
| Mar 2006 | - | $12.12 M(+158.1%) |
| Dec 2005 | $269.00 K(-5.9%) | $4.69 M(-24.2%) |
| Sept 2005 | - | $6.20 M(-17.9%) |
| June 2005 | - | $7.55 M(-18.2%) |
| Mar 2005 | - | $9.22 M(-14.8%) |
| Dec 2004 | $286.00 K(-6.5%) | $10.82 M(-13.6%) |
| Sept 2004 | - | $12.52 M(+41.1%) |
| June 2004 | - | $8.87 M(+33.0%) |
| Mar 2004 | - | $6.67 M(-13.3%) |
| Dec 2003 | $306.00 K(+5.8%) | $7.70 M(+59.2%) |
| Sept 2003 | - | $4.83 M(+156.5%) |
| June 2003 | - | $1.88 M(-16.2%) |
| Mar 2003 | - | $2.25 M(+12.8%) |
| Dec 2002 | $289.20 K(+48.6%) | $1.99 M(+50.2%) |
| Sept 2002 | - | $1.33 M(+51.3%) |
| June 2002 | - | $877.50 K(-17.4%) |
| Mar 2002 | - | $1.06 M(-32.4%) |
| Dec 2001 | $194.60 K | $1.57 M(+81.1%) |
| Sept 2001 | - | $868.10 K(+15.9%) |
| June 2001 | - | $748.80 K |
FAQ
- What is Galectin Therapeutics annual total current assets?
- What is the all time high annual current assets for Galectin Therapeutics?
- What is Galectin Therapeutics annual current assets year-on-year change?
- What is Galectin Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly current assets year-on-year change?
What is Galectin Therapeutics annual total current assets?
The current annual current assets of GALT is $27.71 M
What is the all time high annual current assets for Galectin Therapeutics?
Galectin Therapeutics all-time high annual total current assets is $48.21 M
What is Galectin Therapeutics annual current assets year-on-year change?
Over the past year, GALT annual total current assets has changed by +$7.16 M (+34.83%)
What is Galectin Therapeutics quarterly total current assets?
The current quarterly current assets of GALT is $28.67 M
What is the all time high quarterly current assets for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly total current assets is $52.70 M
What is Galectin Therapeutics quarterly current assets year-on-year change?
Over the past year, GALT quarterly total current assets has changed by +$7.05 M (+32.65%)